Randomized phase II trial comparing IG-001 versus paclitaxel against first-line advanced ovarian cancer.

被引：0
|
作者：
Trieu, Vuong N. [1 ]
Choi, Monica [1 ]
Hwang, Larn [1 ]
D'Cruz, Osmond [1 ]
机构：
[1] Sorrento Therapeut, Irvine, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.5590
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5590
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II trial of satraplatin and paclitaxel in the first-line treatment of advanced non-small cell lung cancer
    Shipley, D.
    Spigel, D. R.
    Cavanaugh, C.
    Moore, Y.
    Hainsworth, J. D.
    Jones, S.
    Burris, H. A., III
    Sade, L.
    Yardley, D. A.
    Greco, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study
    Vici, Patrizia
    Colucci, Giuseppe
    Giotta, Francesco
    Sergi, Domenico
    Filippelli, Gianfranco
    Perri, Pasquale
    Botti, Claudio
    Vizza, Enrico
    Carpino, Armando
    Pizzuti, Laura
    Latorre, Agnese
    Giannarelli, Diana
    Lopez, Massimo
    Di Lauro, Luigi
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
  • [33] A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study
    Patrizia Vici
    Giuseppe Colucci
    Francesco Giotta
    Domenico Sergi
    Gianfranco Filippelli
    Pasquale Perri
    Claudio Botti
    Enrico Vizza
    Armando Carpino
    Laura Pizzuti
    Agnese Latorre
    Diana Giannarelli
    Massimo Lopez
    Luigi Di Lauro
    Journal of Experimental & Clinical Cancer Research, 30
  • [34] Phase II trial of oxaliplatin (OXA) combined with paclitaxel (P) as first-line chemotherapy for patients (pts) with advanced ovarian cancer (AOC): Preliminary results
    Deplanque, G
    Goupil, A
    Fabbro, M
    Levy, E
    Rixe, O
    Benettaib, B
    Cvitkovic, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 467S - 467S
  • [35] Interferon gamma in the first-line therapy of ovarian cancer:: a randomized phase III trial
    Windbichler, GH
    Hausmaninger, H
    Stummvoll, W
    Graf, AH
    Kainz, C
    Lahodny, J
    Denison, U
    Müller-Holzner, E
    Marth, C
    BRITISH JOURNAL OF CANCER, 2000, 82 (06) : 1138 - 1144
  • [36] Report of first-stage accrual for NCI 5886, a phase II study of erlotinib, carboplatin and paclitaxel as first-line treatment of ovarian cancer.
    Blank, S. V.
    Curtin, J. P.
    Goldman, N. A.
    Runowicz, C. D.
    Speyer, J. L.
    Tiersten, A. D.
    Dancey, J.
    Wadler, S.
    Muggia, F. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 274S - 274S
  • [37] A phase II study of anlotinib as first-line maintenance therapy for advanced ovarian cancer
    Li, Siyuan
    Zhang, Yanqin
    Yang, Rong
    Yang, Qingfan
    Han, Shuangyan
    Li, Dan
    Zhang, Zhenhua
    Wen, Qinglian
    ANTI-CANCER DRUGS, 2025, 36 (05) : 394 - 400
  • [38] First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix - A phase II study
    Piver, MS
    Ghamande, SA
    Eltabbakh, GH
    O'Neill-Coppola, C
    GYNECOLOGIC ONCOLOGY, 1999, 75 (03) : 334 - 337
  • [39] A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer
    Kang, H. J.
    Chang, H. M.
    Kim, T. W.
    Ryu, M-H
    Sohn, H-J
    Yook, J. H.
    Oh, S. T.
    Kim, B. S.
    Lee, J-S
    Kang, Y-K
    BRITISH JOURNAL OF CANCER, 2008, 98 (02) : 316 - 322
  • [40] A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer
    H J Kang
    H M Chang
    T W Kim
    M-H Ryu
    H-J Sohn
    J H Yook
    S T Oh
    B S Kim
    J-S Lee
    Y-K Kang
    British Journal of Cancer, 2008, 98 : 316 - 322
12345